• Dry Cracked Skin
  • Impetigo
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

Nature-based skin care effective as adjunct to prescription rosacea therapy

Dermatology TimesDermatology Times, March 2019 (Vol. 40, No. 3)
Volume 40
Issue 3

Burt's Bees skin care products may be a effective as an adjunct to prescription therapy in the management of rosacea, according to data published in the February issue of Journal of Drugs in Dermatology which was reported at the American Academy of Dermatology Annual Meeting this month.


Burt's Bees skin care products may be a effective as an adjunct to prescription therapy in the management of rosacea. (Milan Lipowski - stock.adobe.com)

Burt's Bees skin care products may be a effective as an adjunct to prescription therapy in the management of rosacea, according to data published in the February issue of Journal of Drugs in Dermatology which was reported at the American Academy of Dermatology Annual Meeting this month.

Eighty female patients with rosacea between the ages of 25 and 70 years old were first treated with topical 0.75% metronidazole gel twice daily. Following baseline assessments, the patients were randomized to receive – in conjunction with the topical therapy - either a four-week regimen consisting of a cleanser containing natural oils, beeswax and witch hazel and day and night creams containing natural oils, glycerin, and botanical anti-inflammatories or a four-week control regimen of cetyl alcohol, sodium lauryl sulphate-containing cleanser, and glycerin, polyisobutene-containing lotion.

Blinded investigator global assessment of rosacea, investigator-rated, and subject-rated overall skin appearance was assessed again at two and four weeks. The investigational regimen clinically and statistically improved erythema by 28%, telangiectasia by 26% and papules/pustules by 34% (p<0.001) while the control regimen improved rosacea symptoms by 8 to 12%.

Draelos, ZD, Gunt, H, and Levy, SB. Natural skin care products as adjunctive to prescription therapy in moderate to severe rosacea. J Drugs Dermatol. 2019; 18(2):141-146

Related Videos
Botulinum toxin for rosacea
© 2023 MJH Life Sciences

All rights reserved.